IDEXX LABORATORIES INC /DE is 19.1x more valuable than Celldex Therapeutics, Inc. by market capitalization ($43.93 B vs $2.30 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IDXX | CLDX |
|---|---|---|
| Market cap | $43.93 B | $2.30 B |
| US-listed rank | #351 | #1997 |
| Revenue (latest FY) | $4.30B | $1.54M |
| Net income (latest FY) | $1.06B | -$258.76M |
| Net margin | 24.6% | -16748.0% |
| P/E (trailing FY) | 41.5 | - |
| SEC filings | 2,148 | 1,268 |
IDEXX LABORATORIES INC /DE is 19.1x more valuable than Celldex Therapeutics, Inc. by market capitalization ($43.93 B vs $2.30 B).
In their latest fiscal years, IDEXX LABORATORIES INC /DE reported $4.30B in revenue while Celldex Therapeutics, Inc. reported $1.54M.
Full pages: IDEXX LABORATORIES INC /DE and Celldex Therapeutics, Inc., or browse the full rankings.